RBR-10jpb6v7招募中不适用
Adult Acute Lymphoblastic Leukemia treated with pediatric regimen – a prospective observational study
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo0 个研究点开始时间: 2023年9月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16Y 至 50Y（—）
入选标准
- •Patients between 16 and 50 years-old; both genders; with newly diagnosed Acute Lymphoblastic Leukemia - ALL; negative for Philadelphia chromosome; not previously treated (except for hydroxyurea, corticosteroids, or intrathecal chemotherapy) with at least 20% blasts in peripheral blood and/or bone marrow
排除标准
- •Burkitt leukemia. Prior chronic myeloproliferative disease. Philadelphia chromosome positivity. ECOG>2. Total bilirubin>2x upper limit of normality. Transaminases>5x ULN. Creatinine>2,5 mg/dl. Positive serology for HIV or HTLV. Heart failure NYHA Class III or IV. Severe psychiatric disorder which prevents adequate compliance. Prior treatment with intravenous chemotherapy, except for hydroxyurea and corticosteroids. Refusal to participate in the study. Down syndrome
研究者
相似试验
招募中
3 期
Acute Lymphoblastic Leukemia treatment protocol for children and adolescentRBR-6pmfz8Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
已完成
不适用
Treatment of acute lymphoblastic leukemia (ALL) in adults age 40 - 70 years inclusive with chemotherapy including a pre-induction course for rapid tumor load reduction and prolonged maintenance chemotherapyAcute Lymphoblastic LeukemiaLymphoid leukaemiaCancerISRCTN00446029Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)55
招募中
2 期
Treatment protocol for adult acute lymphoblastic leukemia (-ALL/MRD2023-)acute lymphoblastic leukemiaJPRN-jRCTs071220071Koichi Akashi210
已完成
2 期
Treatment protocol for adult acute lymphoblastic leukemia -ALL/MRD2014acute lymphoblastic leukemiaJPRN-UMIN000012382Fukuoka Blood & Marrow Transplant Group100
招募中
不适用
Treatment protocol for adult acute lymphoblastic leukemiaJPRN-UMIN000037626Japan Study Group for Cell Therapy and Transplantation200